Global private equity and venture capital news and research

Posts Tagged ‘NeoMed Management’

10 August 2015

VC-backed JenaValve closes $26.5m Series C round

dollars cash money Venture capital-backed JenaValve Technology, a maker of transcatheter aortic valve repair solutions, has closed a $26.5m Series C financing round.

7 January 2015

NeoMed co-leads $19.7m Series D for drug developer Genkyotex

pills-1111307-m European venture capital firm NeoMed Management has led a CHF20m ($19.7m) financing round for Genkyotex, a company developing drugs to treat diseases of the kidney, liver, lung and skin.

15 September 2014

EIF investment helps NeoMed close Fund V on €92.1m

medical-care-962546-m Medical-focused venture capital firm NeoMed Management has held the final close of its Innovation V fund on €92.1m ($122m).

9 September 2014

Meritech Capital leads $35m Series A round for root canal company Sonendo

tooth teeth scan medical healthcare Meritech Capital Partners has led a $35m financing round for root canal therapy business Sonendo to boost its tech development, fund clinical studies and commercialise its Gentlewave system.

25 March 2014

Axonics raises $32.6m in Edmond de Rothschild-led Series A

medical monitor Edmond de Rothschild Investment Partners has led a $32.6m Series A funding round for Axonics Modulation Technologies, which is focused on developing implantable neuromodulation technology.

23 July 2013

German medical device company JenaValve Technology inks $62.5m investment

German medical device company JenaValve Technology has raised $62.5m in a Series C venture round led by Belgium-based investment firm Gimv, alongside new investors including Beijing-based Legend Capital and healthcare-focused Omega Funds.

25 June 2013

Root canal tech company Sonendo cleans up with $18m OrbiMed-led financing

Root canal cleaning technology business Sonendo has tripled its existing financing after raising an $18m round led by OrbiMed Advisors.

27 November 2012

Swiss medtech company Endosense raises $40m VC round

Switzerland-headquartered medical technology company Endosense has raised $40.3m for a Series C financing round led by new investor NGN Capital.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016